北美胰岛素输送设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

北美胰岛素输送设备市场 - 按类型(胰岛素笔、胰岛素泵、胰岛素注射器和喷射注射器)和地区细分

市场快照

North America Insulin Delivery Devices Market overview
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 0 %
North America Insulin Delivery Devices Market key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

胰岛素输送设备的市场直接依赖于不断增加的糖尿病人口。近年来,北美地区的糖尿病患病率惊人地增加。在美国和加拿大等发达国家,糖尿病的发病率一直处于历史最高水平,这主要是由于环境和生活方式的改变。

报告范围

北美胰岛素输送设备市场细分为胰岛素笔、胰岛素泵、胰岛素注射器、喷射注射器。胰岛素笔进一步细分为可重复使用的笔(墨盒)和一次性笔,胰岛素泵进一步细分为胰岛素泵、胰岛素泵储液罐和输液器。

By Product (Value and Volume, 2012-2024)
Reusable Insulin pens (Cartridges in Reusable pens)
Disposable Insulin Pens
Insulin Syringes
Insulin Jet Injectors
Insulin Infusion Pumps
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Geography
North America (Value and Volume, 2012-2024)
USA
Canada
Rest of North America

Report scope can be customized per your requirements. Click here.

主要市场趋势

技术创新正在推动胰岛素输送市场

  • 对胰岛素不断增长的需求导致了巨大的研发活动,以制造不同类型的无痛胰岛素输送设备,例如 CGM 集成胰岛素泵。
  • 最初,注射器是胰岛素输送系统的唯一形式,被认为是痛苦的并且不方便用户使用。因此,诺和诺德、赛诺菲等公司生产了自己的胰岛素笔。它们具有特定的设定剂量,这被认为不仅使用起来不那么痛苦,而且还减少了胰岛素的浪费。根据少数研究,与使用注射器的患者相比,笔可以通过施用准确剂量来限制胰岛素的摄入。
North America Insulin Delivery Devices Market Key Trends

美国在北美胰岛素输送装置市场占有最高的市场份额

  • 北美地区的美国 (US) 拥有最高的糖尿病人口。因此,胰岛素输送装置在美国的销量很高。美国占北美地区近 90% 的市场份额。
  • 该地区的消费者对新技术的接受度很高,预计这将在预测期内推动喷射器市场的销售。 
North America Insulin Delivery Devices Market Growth by Region

竞争格局

  • 2018 年,由少数参与者整合的胰岛素笔和胰岛素泵市场占据了重要的市场份额。但胰岛素注射器市场是一个高度分散的市场;许多市场参与者都是本地的。
  • 近期参与者之间发生的并购帮助这些公司加强了他们的市场占有率,例如,诺和诺德与 Ypsomed 合作提供更好的胰岛素治疗解决方案。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Product (Value and Volume, 2012-2024)

      1. 5.1.1 Reusable Insulin pens (Cartridges in Reusable pens)

      2. 5.1.2 Disposable Insulin Pens

      3. 5.1.3 Insulin Syringes

      4. 5.1.4 Insulin Jet Injectors

      5. 5.1.5 Insulin Infusion Pumps

        1. 5.1.5.1 Insulin Pump Device

        2. 5.1.5.2 Insulin Pump Reservoir

        3. 5.1.5.3 Infusion Set

    2. 5.2 Geography

      1. 5.2.1 North America (Value and Volume, 2012-2024)

        1. 5.2.1.1 USA

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Rest of North America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Becton and Dickenson

    2. 6.2 Medtronic

    3. 6.3 Insulet

    4. 6.4 Tandem

    5. 6.5 Ypsomed

    6. 6.6 Novo Nordisk

    7. 6.7 Sanofi

    8. 6.8 Eli Lilly

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Insulin Delivery Devices Market market is studied from 2018 - 2026.

The North America Insulin Delivery Devices Market is growing at a CAGR of 0% over the next 5 years.

Novo Nordisk, Medtronic, Roche, Ypsomed, Becton and Dickenson are the major companies operating in North America Insulin Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!